Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Apr 6, 2021; 9(10): 2192-2204
Published online Apr 6, 2021. doi: 10.12998/wjcc.v9.i10.2192
Figure 1
Figure 1 Overall survival of patients with early gastric cancer. A: All patients. Overall survival (OS), 77.0 ± 12.1 mo [95% confidence interval (CI): 53.3-100.7]; 3-yr OS rate, 94.1%; 5-yr OS rate, 85%; B: Lymph node metastasis vs none. P < 0.001. Lymph node metastasis group: OS, 69.0 ± 2.7 mo (95%CI: 63.7-74.3); 3-yr OS rate, 60%; 5-yr OS rate, 25%; C: Residual tumor vs none. P = 0.023. Residual tumor group: 3-yr OS rate, 80%; 5-yr OS rate, 62.5%.